UK markets close in 6 hours 32 minutes

Ocular Therapeutix, Inc. (OCUL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.80-0.01 (-0.09%)
At close: 04:00PM EDT
5.78 -0.01 (-0.26%)
After hours: 06:48PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
59,843
58,443
51,494
43,522
17,403
-
Cost of revenue
5,393
5,281
4,540
4,406
2,083
-
Gross profit
54,450
53,162
46,954
39,116
15,320
-
Operating expenses
Research development
67,043
61,055
53,462
50,083
28,694
-
Selling general and administrative
78,857
74,489
72,146
67,070
49,473
-
Total operating expenses
145,900
135,544
125,608
117,153
78,167
-
Operating income or loss
-91,450
-82,382
-78,654
-78,037
-62,847
-
Interest expense
13,621
11,338
7,022
6,671
6,768
-
Total other income/expenses net
-17,537
9,001
13,840
78,122
-86,189
-
Income before tax
-115,266
-80,736
-71,038
-6,553
-155,636
-
Income from continuing operations
-115,266
-80,736
-71,038
-6,553
-155,636
-
Net income
-115,266
-80,736
-71,038
-6,553
-155,636
-
Net income available to common shareholders
-115,266
-80,736
-71,038
-6,553
-155,636
-
Basic EPS
-0.86
-
-0.92
-0.09
-2.56
-1.91
Diluted EPS
-1.01
-
-0.97
-0.98
-2.56
-1.91
Basic average shares
77,960
-
76,875
76,393
60,752
45,273
Diluted average shares
83,729
-
82,644
82,162
60,752
45,273